ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,695Medicare Part D Prescriptions Filled, Including Refills

Rank: 121 out of 783

$770K Total Retail Price of All Prescriptions

Rank: 109 out of 783

412 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 412 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

31% of this provider’s 412 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 8,228 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 668 369 S3 1 2
LISINOPRIL 645 373 2 4
LEVOTHYROXINE SODIUM 412 281 3 1
SIMVASTATIN 407 229 4 3
OMEPRAZOLE 377 274 5 6
CRESTOR 328 247 6 27
HYDROCHLOROTHIAZIDE 309 233 7 12
AMLODIPINE BESYLATE 291 217 8 5
ATORVASTATIN CALCIUM 287 174 9 11
FUROSEMIDE 274 209 10 7
METFORMIN HCL 240 152 11 8
METOPROLOL SUCCINATE 232 170 12 13
CARVEDILOL 227 157 13 21
PANTOPRAZOLE SODIUM 197 98 14 30
WARFARIN SODIUM 166 139 15 10
GABAPENTIN 132 62 16 15
FAMOTIDINE 127 70 17 55
CLOPIDOGREL 126 121 18 29
MIRTAZAPINE 124 89 19 52
LOSARTAN POTASSIUM 123 118 20 18
PROAIR HFA 121 46 21 56
TAMSULOSIN HCL 117 88 22 26
SPIRIVA 115 57 23 59
VENTOLIN HFA 110 34 24 159
ADVAIR DISKUS 110 53 24 50
SERTRALINE HCL 107 88 26 22
CITALOPRAM HBR 105 77 27 19
ATENOLOL 105 93 27 17
NEXIUM 105 38 27 28
ZOLPIDEM TARTRATE 100 60 30 23
SYMBICORT 96 42 31 157
CELEBREX 91 69 32 93
NAMENDA 90 81 33 32
PLAVIX 89 81 34 51
ALENDRONATE SODIUM 88 72 35 25
SPIRONOLACTONE 88 67 35 57
POTASSIUM CHLORIDE 87 69 37 16
METOPROLOL TARTRATE 87 53 37 9
TRAMADOL HCL 85 61 39 20
PREDNISONE 73 48 40 36
HYDROXYZINE HCL 70 47 R 41 165
AMITRIPTYLINE HCL 69 30 R 42 77
TRAZODONE HCL 68 49 43 39
DIOVAN 66 55 44 49
ACETAMINOPHEN-CODEINE 65 30 S3 45 144
AZITHROMYCIN 64 29 46 41
ISOSORBIDE MONONITRATE ER 62 62 47 40
DONEPEZIL HCL 62 62 47 24
GLIMEPIRIDE 60 52 49 34
KLOR-CON M10 58 14 50 137
POLYETHYLENE GLYCOL 3350 57 52 51 43
EXELON 56 47 52 109
METHOCARBAMOL 56 14 R 52 215
TIZANIDINE HCL 56 13 52 133
OXYCODONE HCL-ACETAMINOPHEN 55 0 S2 55 86
ZETIA 55 29 55 80
CYCLOBENZAPRINE HCL 55 28 R 55 63
HUMALOG MIX 75-25 55 17 55 296
INSULIN SYRINGE 55 15 55 82
METHYLPREDNISOLONE 54 33 60 138
PROPRANOLOL HCL 53 23 61 129
CEFDINIR 53 33 61 210
SINGULAIR 52 24 63 90
PROMETHAZINE HCL 52 15 R 63 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.